Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KidneyCare Immuno-optimization in Renal Allografts
NCT05423496Withdrawn
- Sponsor
- CareDx
- Start
- Aug 2022
- Primary completion
- Feb 2023
01
Overview
Randomised, open-label trial (4 arms), sponsored by CareDx. Primary endpoints: Estimated Glomerular Filtration Rate at 24 months, Interstitial Fibrosis/Tubular Atrophy at 24 months and 2 more. Planned start Aug 2022; status: withdrawn.
Beyond the preview
Go deeper on NCT05423496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05423496.